Plunkett Research Online: Anchiano Therapeutics Ltd

ANCHIANO THERAPEUTICS LTD (ANCN) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Anchiano Therapeutics Ltd. (formerly BioCancell Ltd.) is a clinical-stage biotechnology company focused on engineering a targeted gene therapy to improve the standard of care for early-stage bladder cancer. Anchiano has discovered and is developing a biologic agent, inodiftagene, as a new treatment.....


ANCHIANO THERAPEUTICS LTD

Ticker: ANCN
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 972-2-548-6555
Fax: 972-2-548-6550
Address: 1/3/ High-Tech Village, Givat Ram
Jerusalem, 97775 Israel

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Frank HaluskaCEO/Pres.
Jonathan BurginCFO
See More
Anchiano Therapeutics Ltd. (formerly BioCancell Ltd.) is a clinical-stage biotechnology company focused on engineering a targeted gene therapy to improve the standard of care for early-stage bladder cancer. Anchiano has discovered and is developing a biologic agent, inodiftagene, as a new treatment.....See More See More

$USD, In whole numbers 2018201720162015201420132012
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture